Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ProPhase Labs, Inc.
| Metric | ProPhase Labs, Inc. PRPHHealthcare |
|---|---|
| Quality Score | 25 / 100 |
| Revenue (latest) | $4M |
| Net income (latest) | −$15M |
| Operating margin | −415.4% |
| Net margin | −339.3% |
| Return on equity | −420.3% |
| Return on assets | −24.6% |
| Return on capital (ROCE) | −265.8% |
| Debt / equity | 16.07× |
| Revenue growth (YoY) | −35.8% |
| Altman Z″ (distress) | -11.41 |
| Accruals / assets | −10.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.